Reed Ronald C, Dutta Sandeep
Abbott Laboratories, Abbott Park, IL, USA.
Ther Drug Monit. 2006 Jun;28(3):413-8. doi: 10.1097/01.ftd.0000211814.12311.3f.
Divalproex sodium extended-release (divalproex-ER) is a novel formulation intended for once-daily oral administration, either morning or evening. Questions have risen concerning the optimal time for obtaining a blood sample for valproic acid (VPA) concentration in relation to the dose. Trough sampling is easily achieved just before a morning daily dose, but the best time to sample after an evening daily dose is unclear, because collecting a blood sample 21 to 24 hours later may be limited by the operational hours of the laboratory. This investigation provides practical guidance regarding blood sample timing. Steady-state plasma VPA concentration-time profiles from 5 published divalproex-ER studies (healthy subjects and epilepsy patients) were analyzed. The concentration-time profile for each subject/patient was expressed as a percentage of his/her trough concentration and summary statistics computed. Typically, when taking divalproex-ER once daily in the morning, a blood sample collected 21 to 24 hours later is expected to have a concentration within 3% of the trough value. Conversely, for divalproex-ER dosed once-daily in the evening, for example 8 PM, a blood draw 12 to 15 hours later (ie, 8 to 11 AM) will give a plasma VPA concentration value that is 18% to 25% higher, on average, than the trough value. However, waiting longer, (for example 18 to 21 hours, ie 2 to 5 PM) will result in concentration values that are merely 3% to 13% higher than trough values, which may provide acceptable information for monitoring purposes. The greatest deviation from trough VPA concentration occurs around the peak, that is 3 to 15 hours after a once-daily divalproex-ER dose; sampling during this time period is recommended only if a clinical need exists to test for a higher VPA concentration. Despite the apparent smoothness of the VPA concentration-time profile after a once-daily divalproex-ER dose, the timing of the blood sample does matter and impacts the proper interpretation of the VPA concentration.
丙戊酸缓释钠(divalproex - ER)是一种新型制剂,旨在每日口服一次,可在早晨或晚上服用。关于与剂量相关的丙戊酸(VPA)浓度血样采集的最佳时间,已出现了一些问题。在每日早晨剂量前采集谷值血样很容易实现,但晚上每日剂量后最佳采样时间尚不清楚,因为在21至24小时后采集血样可能会受到实验室工作时间的限制。本研究提供了关于血样采集时间的实用指导。分析了5项已发表的丙戊酸缓释钠研究(健康受试者和癫痫患者)的稳态血浆VPA浓度 - 时间曲线。每个受试者/患者的浓度 - 时间曲线表示为其谷值浓度的百分比,并计算汇总统计数据。通常,早晨每日服用一次丙戊酸缓释钠时,21至24小时后采集的血样浓度预计在谷值的3%以内。相反,对于晚上每日服用一次丙戊酸缓释钠,例如晚上8点给药,12至15小时后(即上午8点至11点)采血,血浆VPA浓度值平均比谷值高18%至25%。然而,等待更长时间(例如18至21小时,即下午2点至5点),浓度值仅比谷值高3%至13%,这可能为监测目的提供可接受的信息。与VPA谷值浓度的最大偏差出现在峰值附近,即每日一次丙戊酸缓释钠剂量后3至15小时;仅在临床需要检测更高VPA浓度时才建议在此时间段采样。尽管每日一次丙戊酸缓释钠剂量后VPA浓度 - 时间曲线看似平滑,但血样采集时间确实很重要,并会影响VPA浓度的正确解读。